Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Butavate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

70 API Suppliers, 14 USDMF, 13 CEP/COS, 4 JDMF, 12 EU WC, 17 KDMF, 15 NDC API, 40 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

51 Drugs in Development

51 Drugs in Development

FINISHED DOSAGE FORMULATIONS

243 FDF Dossiers, 99 FDA Orange Book, 71 Europe, 25 Canada, 3 Australia, 9 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.025%, AEROSOL, FOAM;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, SHAMPOO;TOPICAL - 0.05%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 4 DKSH, 8 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 ACG Worldwide, 9 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Topical, 38 Coating Systems & Additives, 24 Solubilizers, 20 Thickeners and Stabilizers, 16 Parenteral, 16 Controlled & Modified Release, 15 Emulsifying Agents, 13 Surfactant & Foaming Agents, 11 Film Formers & Plasticizers, 7 Rheology Modifiers, 6 Granulation, 5 Empty Capsules, 5 Taste Masking, 5 Direct Compression, 4 Vegetarian Capsules, 4 Fillers, Diluents & Binders, 4 API Stability Enhancers, 3 Lubricants & Glidants, 2 Coloring Agents, 1 Co-Processed Excipients, 1 Disintegrants & Superdisintegrants, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

88 News #PharmaBuzz

88 News #PharmaBuzz

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 43 Regulatory FDF Prices

MARKET PLACE

24 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Symbiotec Pharmalab	India	GlaxoSmithKline Inc.	20121126-93-E-103-07(A)	clobetasol propionate	2021-11-10	Symbiotec Pharmalab Pvt. Limited	India	385/2 Gram Pigdamber, Near Hotel Mashal, Off AB Road, Rau, Indore-453 331 (MP) India
29/11/2025	Axplora	Germany	Galderma Korea Co., Ltd.	20121123-93-E-100-06	clobetasol propionate	2012-11-22	Farmabios SpA	Italy	via Pavia 1 27027 GROPELLO CAIROLI (PV) (microchem SRL, Via Turati 2 IT-29017 Fiorenzuola D'Arda (PC), Italy)

Butavate

Butavate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

70 API Suppliers

14 USDMF

13 CEP/COS

4 JDMF

12 EU WC

17 KDMF

15 NDC API

40 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

51 Drugs in Development

FINISHED DOSAGE FORMULATIONS

243 FDF Dossiers

99 FDA Orange Book

71 Europe

25 Canada

3 Australia

9 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.025%

AEROSOL, FOAM;TOPICAL - 0.05%

LOTION;TOPICAL - 0.05%

LOTION;TOPICAL - 0.05%

SHAMPOO;TOPICAL - 0.05%

AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

4 DKSH

8 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 ACG Worldwide

9 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 CD Formulation

1 Clariant

14 Corel Pharma Chem

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

3 Ideal Cures

9 Kerry

3 Kima Chemical

6 Lonza Capsugel

5 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Topical

38 Coating Systems & Additives

24 Solubilizers

20 Thickeners and Stabilizers

16 Parenteral

16 Controlled & Modified Release

15 Emulsifying Agents

13 Surfactant & Foaming Agents

11 Film Formers & Plasticizers

7 Rheology Modifiers

6 Granulation

5 Empty Capsules

5 Taste Masking

5 Direct Compression

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons